The Journal of Immunology, 2003, 171: 2765-2766.
Copyright © 2003 by The American Association of Immunologists
IN THIS ISSUE
IL-6/IL-6R and rheumatoid arthritis
Synovial fluids and sera from rheumatoid arthritis (RA) patients contain elevated levels of IL-6 compared with osteoarthritis patients. Yet it is unclear how IL-6 contributes to the symptomology of RA since cells in the affected joints do not express the IL-6 receptor. Nowell et al. (p. 3202
) determined that RA, but not osteoarthritis, patients had high levels of a soluble IL-6 receptor (sIL-6R) in their synovial fluids. The authors used a murine model of monoarthritic Ag-induced arthritis to study the interaction of IL-6 and sIL-6R. IL-6+/+ mice developed severe joint swelling by day 3 after induction of arthritis with methylated BSA (mBSA), whereas mBSA-injected IL-6-/- mice were unaffected. Coinjection of mBSA and a unimolecular sIL-6R-IL-6 fusion protein (HYPER-IL-6) induced joint swelling in IL-6-/- mice comparable to that seen in mBSA-injected IL-6+/+ mice. The chemokine CCL2 and its receptor CCR2 colocalized with leukocytes in arthritic joints. Human synovial fibroblasts expressed high levels of the IL-6 signal transducing element gp130. Treatment of the fibroblasts with HYPER-IL-6 resulted in increased CCL2 expression that was blocked by inclusion of a mAb against gp130. Injection of wild-type mice with mBSA and soluble gp130 (sgp130) reduced both arthritis severity and CCL2 expression compared with mBSA-treated wild-type mice not given sgp130. The authors suggest that sgp130 blockade of sIL-6R-mediated signaling may be useful in the management of RA.
A better DNA vaccine
Two strategies to enhance the anti-tumor activity of dendritic cells (DC) are to link a specific Ag to an intracellular targeted protein and to cotransfect DNAs encoding a tumor Ag and an anti-apoptotic protein. Both of these approaches have been used successfully by T.-C. Wu and colleagues to enhance the CD8+ T cell response to human papillomavirus (HPV) 16 E7 Ag. In their paper on p. 2970
, Kim et al. combined these strategies. Mice covaccinated with a plasmid DNA encoding the anti-apoptotic protein, BCL-xL, and with one encoding E7 linked to lysosome-associated membrane protein 1 (E7/LAMP-1) had the greatest fold increase of E7-specific CD8+ T cells of three combinations tested. Mutation of the BCL-xL DNA reduced the high functional avidity of the responding CD8+ T cells to the level seen by covaccination with empty vector. CD4L knockout mice vaccinated with E7/LAMP-1 and BCL-xL DNAs had a weaker response than similarly vaccinated wild-type mice but generated 2-fold more E7-specific CD8+ T cells than wild-type mice vaccinated with E7/LAMP-1 alone. Mice vaccinated with the DNA mixture developed fewer HPV tumor nodules than unvaccinated mice or mice vaccinated with E7/LAMP-1 alone, and the anti-tumor response was still strong at seven weeks after vaccination. The data indicate that a combined approach that prolongs the life of dendritic cells enhances anti-tumor immunity even in the absence of CD4+ T cells.
Reactive oxygen species in Ag presentation
Low concentrations of reactive oxygen species (ROS) can act as second messengers in cellular signaling via redox regulation of molecular pathways in both dendritic cells (DC) and T cells. Matsue et al. (p. 3010
) examined the pharmacological impact of ebselen, a seleno-organic compound with multifunctional antioxidant activities, on DC and T cells. Ebselen reduced the growth, survival, and cytokine production of activated murine CD4+ T cells and DC lines. A cell permeant, oxidation-sensitive dye fluoresced in activated DC, demonstrating that stimulated cells generated ROS. Ebselen inhibited fluorescence in both bone marrow-derived DC and CD4+ T cells cocultured with a specific Ag. Proliferation and cytokine production by both cell types was also suppressed by the antioxidant. In vivo, ebselen significantly reduced the ear swelling in hapten-sensitized mice challenged with the same hapten compared with animals given vehicle alone. Oral administration of ebselen during the sensitization and postchallenge phases was most effective. The authors conclude that low concentrations of ROS are important in bidirectional DC-T interactions during Ag presentation. They propose that ebselen could be beneficial in preventing inflammatory skin reactions.
T cell-mediated hepatitis
T cell-derived IL-4 is implicated in the damage seen in several liver diseases. Although it is known that IL-4 activates STAT6, there are conflicting data regarding the contributions of IL-4 and STAT6 to subsequent hepatocyte destruction. Jaruga et al. (p. 3233
) studied Con A-induced hepatitis in IL-4- and STAT6-deficient mice. Injection of Con A into wild-type miceinduced high levels of STAT6 phosphorylation within one to three hours, whereas STAT6 phosphorylation was suppressed in Con A-injected IL-4-/- mice. Likewise, Con A-injected STAT6-/- and IL-4-/- mice did not develop the liver necrosis or elevated serum levels of liver enzymes seen in injected wild-type animals. Adoptive transfer of wild-type hepatic mononuclear cells restored Con A-induced liver injury only in the IL-4-/- mice. Infiltration of neutrophils and eosinophils into the livers of Con A-injected wild-type mice was markedly decreased in Con A-injected STAT6-/- mice. This decreased infiltration was accompanied by decreased expression of eotaxin-1 and eotaxin-2 in hepatocytes and hepatic sinusoidal endothelial cells from STAT6-/- mice compared with wild-type mice. IL-5 serum levels also were lower in the STAT6- and IL-4-deficient animals. The authors conclude that eotaxins and IL-5, induced by IL-4/STAT6 interaction, recruit the eosinophils and neutrophils that cause the Con A-induced liver damage.
The immune synapse and T cell fate
Positive selection of CD4+8- or CD4-8+ T cells is dependent on TCR signaling resulting from interactions between CD4+8+ cortical thymocytes and thymic epithelial cells. Yet the molecular signals involved in positive selection are poorly understood. Hare et al. (p. 2825
) developed an in vitro system to recreate epithelial cell-CD4+8+ thymocyte interactions. Each of the two murine cell types was differentially labeled with fluorescent markers and incubated for 30 min following cocentrifugation. Analyses by immunofluorescence and cell sorting demonstrated formation of conjugates consisting of a single epithelial cell bound by thymocytes. Conjugates did not form if the T cells were TCR-deficient or the epithelial cells lacked MHC. Using appropriate Abs and inhibitors, the authors showed that actin polymerization and tyrosine phosphorylation occurred at the point of epithelial cell contact, and intracellular calcium levels increased in the thymocytes. Redistribution of several T cell surface markers and other proteins was detected at the immune synapse in the conjugates. However, CD4+8+ thymocytes failed to develop lipid rafts at the point of cell contact but did so when the stromal cells were infected with an adenovirus vector expressing human CD80. Expression of CD80 also resulted in a reduction in positive selection in the aggregate cultures. The authors conclude that CD80 costimulation influences TCR signaling and CD4+8+ cell fate by differential lipid raft recruitment.
Non-immune function of MHC proteins
Decreased expression of MHC class I glycoproteins is often associated with the ability of malignant cells to escape immune surveillance. Yet the molecular mechanism by which a lack of MHC class I molecules contributes to the malignant phenotype is unclear. Assa-Kunik et al. (p. 2945
) examined H-2k-deficient and H-2k-expressing clones derived from the mouse B16B6 melanoma. Clones that had gained the capacity to express H-2k, either by transfection or by reversion, were non-tumorigenic, and they exhibited binding of insulin to its membrane-associated receptor (IR). Clones expressing H-2k induced tumors; they did not bind insulin and the IR was retained in intracellular compartments. IR was differentially glycosylated and poorly phosphorylated in H-2k-deficient clones compared with the IR in H-2k-expressing clones. Addition of insulin to H-2k-expressing clones maintained in serum-free medium reduced the percentage of apoptotic cells and increased intracellular activity of the protein kinase B (PKB)/Akt kinase. H-2k-deficient clones, able to survive in serum-free medium without insulin, had high constitutive activation of PKB/Akt. An inhibitor of an up-stream regulator of PKB/Akt decreased the intracellular levels of the enzyme and induced apoptosis in the cells. The authors propose that loss of expression of H-2k promotes malignancy through a decreased demand for insulin via deregulation of PKB/Akt activity.
Vaccination with heat-killed bacteria
Vaccination with live microorganisms induces specific effector and memory T cells. However, there are conflicting reports about the relationship between effector and memory T cells and about the ability of heat-killed microorganisms to elicit effector responses. Lefrançois et al. (p. 2832
) examined T cell responses in C57BL/6 mice immunized with live Listeria monocytogenes (LM) or heat-killed LM (HKLM). A recombinant LM virus expressing a truncated OVA protein was used to generate CD8+ T cells that could be detected by an H-2Kb tetramer containing an OVA peptide. Immunization with LM and HKLM resulted in similar levels of activated CD8+ T cells in the lung and spleen at day five. The T cell response to LM infection continued to increase, whereas the response to HKLM rapidly decreased. The number of Ag-specific memory cells detected in the lung and spleen three weeks after immunization was substantially higher in LM immunized animals. CD8+ T cells from HKLM-immunized mice challenged with LM were able to kill the bacteria at a higher level and earlier than non-immunized mice but at a lower level and later compared with LM-immunized mice. CD8+ T cells from the HKLM-immunized animals had an early, brief clonal expansion and lytic activity after peptide challenge in vivo and produced IFN-
after peptide challenge in vitro. Thus, a heat-killed bacteria vaccine induces a small number of effector CD8+ T cells that develop into memory cells.
Summaries written by Dorothy L. Buchhagen, Ph.D.
Related articles in The JI:
- Modeling TCR Signaling Complex Formation in Positive Selection
- Katherine J. Hare, Judit Pongracz, Eric J. Jenkinson, and Graham Anderson
The JI 2003 171: 2825-2831.
[Abstract]
[Full Text]
- Sustained Response Initiation Is Required for T Cell Clonal Expansion But Not for Effector or Memory Development In Vivo
- Leo Lefrançois, Amanda Marzo, and Kristina Williams
The JI 2003 171: 2832-2839.
[Abstract]
[Full Text]
- Alterations in the Expression of MHC Class I Glycoproteins by B16BL6 Melanoma Cells Modulate Insulin Receptor-Regulated Signal Transduction and Augments Resistance to Apoptosis
- Efrat Assa-Kunik, Daniel Fishman, Sigal Kellman-Pressman, Sylvia Tsory, Shira Elhyany, Ofer Baharir, and Shraga Segal
The JI 2003 171: 2945-2952.
[Abstract]
[Full Text]
- Enhancing DNA Vaccine Potency by Combining a Strategy to Prolong Dendritic Cell Life with Intracellular Targeting Strategies
- Tae Woo Kim, Chien-Fu Hung, David Boyd, Jeremy Juang, Liangmei He, Jeong Won Kim, J. Marie Hardwick, and T.-C. Wu
The JI 2003 171: 2970-2976.
[Abstract]
[Full Text]
- Generation and Function of Reactive Oxygen Species in Dendritic Cells During Antigen Presentation
- Hiroyuki Matsue, Dale Edelbaum, David Shalhevet, Norikatsu Mizumoto, Chendong Yang, Mark E. Mummert, Junichi Oeda, Hiroyuki Masayasu, and Akira Takashima
The JI 2003 171: 3010-3018.
[Abstract]
[Full Text]
- Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130
- Mari A. Nowell, Peter J. Richards, Sankichi Horiuchi, Naoki Yamamoto, Stefan Rose-John, Nicholas Topley, Anwen S. Williams, and Simon A. Jones
The JI 2003 171: 3202-3209.
[Abstract]
[Full Text]
- Crucial Role of IL-4/STAT6 in T Cell-Mediated Hepatitis: Up-Regulating Eotaxins and IL-5 and Recruiting Leukocytes
- Barbara Jaruga, Feng Hong, Rui Sun, Svetlana Radaeva, and Bin Gao
The JI 2003 171: 3233-3244.
[Abstract]
[Full Text]